[{"Assets_0_Q3_USD":698616000.0,"CommonStockSharesOutstanding_0_Q3_shares":58877691.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-277011000.0,"NetIncomeLoss_1_Q3_USD":-106173000.0,"NetIncomeLoss_3_Q3_USD":-309122000.0,"StockholdersEquity_0_Q3_USD":448291000.0,"Ticker":"AGIO","CIK":"1439222","name":"AGIOS PHARMACEUTICALS, INC.","OfficialName":"Agios Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1422760526.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191031"}]